Six studies highlight advancements in AI-powered tumor microenvironment profiling, genomic analysis, biomarker identification, immune-related adverse event prediction and novel drug targets, paving the way for precision oncology BostonGene, a leading provider of AI-driven molecular and immune…
BostonGene to present RNA Sequencing and AI advancements in tumor microenvironment profiling and precision oncology at SITC 2024
Share.
